Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC)

Author: Vestermark Lene   Jacobsen Anders   Qvortrup Camilla   Hansen Flemming   Bisgaard Claus   Baatrup Gunnar   Rasmussen Peter   Pfeiffer Per  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.47, Iss.3, 2007-12, pp. : 428-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content